Updating your copy deck submissions to include document name and description
What does this mean?
With the increase in digital activities to address reduced in-person access to healthcare professionals, many APSs are being repurposed from a print format to a digital format or are being attached as digital downloads. In these situations, APSs are given document names and/or descriptions to identify them.
Why should we consider this?
The PAAB has seen an increase in the use of document names and/or descriptions that have not been reviewed during the preclearance process and do not meet the "name convention" requirements outlined in Clarification regarding of digitization of APS. This has resulted in a number of advertising violations.
We recommend including this information as part of the original submission for the APS. This avoids the need to create a new submission specifically for the review of the document name and/or description at a later date when, for example, you wish to add the APS as an attachment to an email, as a downloadable item in the CPS or “resource library” on your website, etc.
What should we keep in mind?
The places in which these document names and descriptions are presented often do not contain enough space for indications and fair balance. Therefore, we recommend keeping the name and descriptions claim neutral (no direct or implied therapeutic mention).
Current copy deck:
Project: Internal use |
VERANT* Market Experience Leave behind |
Meta Title: Appears in the title bar of browser window |
Market experience data for VERANT in the treatment of psoriasis |
Content provided for digital attachment:
Document Name: |
VERANT Market Experience Leave behind |
Document Description |
Market experience data for VERANT in the treatment of psoriasis |
The document description contains a therapeutic message that requires indication and fair balance to be presented. It is not acceptable when it stands alone. Please note that content within the downloadable document is insufficient to address this issue.
Current copy deck:
Project: Internal use |
#1 dispensed_VERANT |
Meta Title: Appears in the title bar of browser window |
VERANT market experience |
Content provided for digital attachment:
Document Name: |
#1 dispensed_VERANT |
Document Description |
VERANT market experience |
The document name is an incomplete claim (#1 dispensed in what market segment?) which, furthermore, requires indication, fair balance and reference list to be presented. It is not acceptable when it stands alone. Please note that the content within the downloadable document is insufficient to address this issue.
Revised copydeck submission:
Project: Internal use |
#1 dispensed_VERANT |
Document Name: |
VERANT Experience Leave Behind |
Document Description |
Learn more about VERANT’s market experience |
Meta Title: Appears in the title bar of browser window |
VERANT market experience |
Content provided for digital attachment:
Document Name: |
VERANT Experience Leave Behind |
Document Description |
Learn more about VERANT’s market experience |
Meta Data |
VERANT market experience |
The document name and description are acceptable when they stand alone.
* VERANT is a fictitious healthcare product
Never miss an update. Get the latest PAAB info delivered right to your email address.
In an effort to constantly serve our clients better, PAAB has unveiled a new electronic submission process(eFiles). Effective January 2, 2008 all submissions will have to be submitted via the eFiles system. Please have a Senior Official (Director level) send an email to the administration team at review@paab.ca with the contact information of the person(s) who will be designated as administrator(s) for your company. Click on eFiles, on the menu, then eFiles Tutorial for a tutorial on how eFiles works.
Please contact the admin team at PAAB if you need assistance with eFiles
The Accelerated Preclearance Pathway
Learn more and share your feedback by April 14
Click here to provide feedback